Oct 22 (Reuters) - Boiron SA BOIR.PA :
* Q3 2020 REVENUE DOWN 18,5% VERSUS 2019
* Q4 WILL BE POSITIVELY IMPACTED BY NEW PRODUCT LAUNCHES
* WE EXPECT TO SEE A DECREASE IN SALES AND EARNINGS IN 2020
* WE ARE DETERMINED TO CONTINUE OUR EFFORTS TO MAINTAIN
REIMBURSEMENT OF HOMEOPATHIC MEDICINES IN FRANCE, REFLECTING
DEMAND OF MILLIONS OF PATIENTS WHO USE THEM.
Source text for Eikon: ID:nACT65729
Further company coverage: BOIR.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))